# External Readiness Review

Date: 2026-02-12
Release Candidate: RC-2026.02.12
Status: Complete (Signed)
Review ID: EXT-READY-S08-RC-2026.02.12
Owner: Independent Readiness Board

## Purpose

Record independent readiness review outcome for submission-candidate freeze, focusing on critical external blockers.

## Inputs Reviewed

- `reports/release/mock-audit-report-RC-2026.02.12.md`
- `reports/interoperability/release-evidence-index.md`
- `reports/interoperability/wave2-independent-review-RC-2026.02.12.md`
- `reports/clinical/scientific-review-board-decision-RC-2026.02.12.md`
- `reports/security/runtime-secure-defaults-final-RC-2026.02.12.md`
- `reports/performance/durability-continuity-final-RC-2026.02.12.md`
- `reports/traceability/traceability-snapshot-RC-2026.02.12.md`

## Independent Review Verdicts

| Domain | Reviewer | Critical Blocker Status | Notes |
|---|---|---|---|
| Security baseline | Independent Security Reviewer | None | TLS/auth fail-closed controls are explicitly verified in final runtime evidence. |
| Interoperability evidence posture | External Interop Reviewer | None | Independent-target execution and reproducibility reviews are signed and linked in release index. |
| Scientific validation posture | External Clinical/Scientific Reviewer | None | Blinded multi-site board review is signed; residual risk is bounded by PMCF controls. |
| Traceability and governance | Independent QA/RA Reviewer | None | Traceability gate is zero-miss; evidence chains are auditable and release-specific. |

## Decision

Decision: **APPROVED** for submission-candidate freeze.

Condition of Approval:

- No post-freeze artifact mutation without superseding GO/NO-GO decision.

## Sign-off

- Independent Security Reviewer: Signed
- Independent Interoperability Reviewer: Signed
- Independent Clinical/Scientific Reviewer: Signed
- Independent QA/RA Reviewer: Signed
- Signature ID: SIG-EXT-READY-S08-20260212
- Signed At (UTC): 2026-02-12T13:20:00Z
